IKT
INHIBIKASE THERAPEUTICS INC
Institutional Ownership · Q4 2025
Filing: Q4 2025INHIBIKASE THERAPEUTICS INC (IKT) is held by 69 institutional investors with combined holdings of $5.0B. Major holders include Stonepine Capital Managem, Sands Capital Alternative, Soleus Capital Management.
Institutional Holders
69
Total Value
$5.0B
Ownership %
74.0%
🏦 Top Institutional Holders
Stonepine Capital Management, LLC
2.3M shares
$4.8B
1.78% ownership
Sands Capital Alternatives, LLC
13.0M shares
$26.7M
9.86% ownership
Soleus Capital Management, L.P.
10.9M shares
$22.3M
8.24% ownership
Fairmount Funds Management LLC
8.6M shares
$17.7M
6.53% ownership
Trails Edge Capital Partners, LP
6.2M shares
$12.7M
4.68% ownership